Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*

Exclusive Premium Statistic

U.S. top 20 prescribed drugs based on sales 2016 This statistic depicts the U.S. top 20 prescription drugs based on total sales in 2016. In that year, Harvoni generated some 10 billion U.S. dollars in sales. Thus, Harvoni was the second ranked drug in the United States based on revenue. Harvoni is manufactured by Gilead Sciences, a U.S. biotech company headquartered in Foster City, California.
Show more
Drug (Company)Sales in billion U.S. dollars
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Drug (Company)Sales in billion U.S. dollars
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account


only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account


only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Download Settings Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Description Source More information
This statistic depicts the U.S. top 20 prescription drugs based on total sales in 2016. In that year, Harvoni generated some 10 billion U.S. dollars in sales. Thus, Harvoni was the second ranked drug in the United States based on revenue. Harvoni is manufactured by Gilead Sciences, a U.S. biotech company headquartered in Foster City, California.
Show more
Release date
May 2017
Region
United States
Survey time period
2016
Supplementary notes
* Non-discounted spending.
Open this statistic in...

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom

Related Studies: Available to Download in PDF or PPTX Format

Pharmaceutical brands: Crestor and Nexium (AstraZeneca)
Pharmaceutical brands: Crestor and Nexium (AstraZeneca)

All Information
in one Presentation

Pharmaceutical brands: Crestor and Nexium (AstraZeneca)

Everything On "Pharmaceutical brands: Crestor and Nexium (AstraZeneca)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "U.S. pharmaceutical industry"

  • Contribution to global pharma
  • Overview
  • Companies
  • Research and development
  • Generics
  • Outlook
  • The consumer's view
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News
News